Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.

2.

More pain, more gain? New biopsy technique found to improve prostate cancer detection

3.

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

4.

Could the Prostate Cancer Story of Francis Collins Dissuade Men from Active Surveillance?

5.

Gene therapies for BCG-unresponsive bladder cancer have high response rates.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot